ACADIA Pharmaceuticals
ACAD
#3690
Rank
S$3.75 B
Marketcap
$22.57
Share price
-1.47%
Change (1 day)
-25.93%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2024 (TTM): S$59.97 Million

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are S$0.89 Billion. In 2023 the company made an earning of -S$68.68 Million, an increase over its 2022 earnings that were of -S$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$59.97 M-187.33%
2023 -S$68.68 Million-76.09%
2022 -S$0.29 Billion27.41%
2021 -S$0.23 Billion-40.38%
2020 -S$0.38 Billion19.88%
2019 -S$0.32 Billion-3.92%
2018 -S$0.33 Billion-15.04%
2017 -S$0.39 Billion6.33%
2016 -S$0.37 Billion64.55%
2015 -S$0.23 Billion77.47%
2014 -S$0.13 Billion143.69%
2013 -S$51.07 Million81.93%
2012 -S$28.07 Million-8.73%
2011 -S$30.76 Million-251.39%
2010 S$20.31 M-133.2%
2009 -S$61.19 Million-30.82%
2008 -S$88.45 Million6.43%
2007 -S$83.11 Million25.89%
2006 -S$66.02 Million36.99%
2005 -S$48.19 Million37.22%
2004 -S$35.12 Million19.96%
2003 -S$29.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$43.7 Million-170.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$1.64 Billion-2,749.53%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.65 B 22,089.80%๐Ÿ‡บ๐Ÿ‡ธ USA
S$24.75 B 40,112.92%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$9.26 Billion-15,140.22%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$51.99 Million-184.45%๐Ÿ‡บ๐Ÿ‡ธ USA